% alzhub.org library filter % Source: https://alzhub.org/research?author=Iwata+A % 7 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{sato2023-39081988, author = {Sato, K. and Niimi, Y. and Ihara, R. and Suzuki, K. and Iwata, A. and Iwatsubo, T.}, title = {{APOE -ε4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapy}}, journal = {Frontiers in dementia}, year = {2023}, doi = {10.3389/frdem.2023.1320329}, pmid = {39081988}, url = {https://doi.org/10.3389/frdem.2023.1320329} } @article{atri2026-42128444, author = {Atri, A. and Apostolova, L. G. and Iwata, A. and Wessels, A. M. and Atkins, A. and Lu, M. and Ye, W. and Ryan, S. and Doty, E. G.}, title = {{Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial}}, journal = {Neurology: Clinical Practice}, year = {2026}, doi = {10.1212/CPJ.0000000000200621}, pmid = {42128444}, url = {https://doi.org/10.1212/CPJ.0000000000200621} } @article{kurihara2024-38539238, author = {Kurihara, M. and Matsubara, T. and Morimoto, S. and Arakawa, A. and Ohse, K. and Kanemaru, K. and Iwata, A. and Murayama, S. and others}, title = {{Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer's disease and other neurodegenerative diseases}}, journal = {Acta neuropathologica communications}, year = {2024}, doi = {10.1186/s40478-024-01758-3}, pmid = {38539238}, url = {https://doi.org/10.1186/s40478-024-01758-3} } @article{iwatsubo2018-29753531, author = {Iwatsubo, T. and Iwata, A. and Suzuki, K. and Ihara, R. and Arai, H. and Ishii, K. and Senda, M. and Ito, K. and others}, title = {{Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2018}, doi = {10.1016/j.jalz.2018.03.009}, pmid = {29753531}, url = {https://doi.org/10.1016/j.jalz.2018.03.009} } @article{sabbagh2020-32463070, author = {Sabbagh, M. N. and Boada, M. and Borson, S. and Doraiswamy, P. M. and Dubois, B. and Ingram, J. and Iwata, A. and Porsteinsson, A. P. and others}, title = {{Early Detection of Mild Cognitive Impairment (MCI) in an At-Home Setting}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2020}, doi = {10.14283/jpad.2020.22}, pmid = {32463070}, url = {https://doi.org/10.14283/jpad.2020.22} } @article{iwata2002-12484568, author = {Iwata, A. and Chen, X. H. and McIntosh, T. K. and Browne, K. D. and Smith, D. H.}, title = {{Long-term accumulation of amyloid-beta in axons following brain trauma without persistent upregulation of amyloid precursor protein genes}}, journal = {Journal of neuropathology and experimental neurology}, year = {2002}, doi = {10.1093/jnen/61.12.1056}, pmid = {12484568}, url = {https://doi.org/10.1093/jnen/61.12.1056} } @article{sato2026-a8cec4bf, author = {Sato, K. and Niimi, Y. and Nakashima, S. and Igarashi, A. and Iwata, A. and Kasuga, K. and Nemoto, K. and Higashi, S. and others}, title = {{Protocol for the 2026 Nationwide Survey of Dementia Specialists on the Real-World Implementation of Anti-Amyloid Antibody Therapies in Japan: Clinical Practice, Blood Biomarkers, and Preference Experiments}}, journal = {medRxiv}, year = {2026}, doi = {10.64898/2026.06.30.26356494}, url = {https://doi.org/10.64898/2026.06.30.26356494} }